Johnson & Johnson (JNJ) — Technical state
As of 2026-11-05 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: Uptrend stack intact — Trades +2.5% vs the 50-day and +9.9% vs the 200-day average, 3.4% below the 52-week high and +48.8% off the 52-week low. Computed from daily closes. (as of 2026-11-05)
- Trend: Johnson & Johnson trades 2.5% above its 50-day and 9.9% above its 200-day moving average. (as of 2026-11-05)
Johnson & Johnson develops, makes and sells healthcare products worldwide through two arms: Innovative Medicine, covering prescription treatments for cancer, immune disease, infection and heart and metabolic conditions, and MedTech, covering surgical, orthopaedic, cardiovascular and vision products, including contact lenses and lenses used in cataract surgery. It sells through wholesalers, distributors, hospitals and clinicians rather than direct to patients in most cases.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the JNJ overview. Research diary readings, not advice.
Trades +2.5% vs the 50-day and +9.9% vs the 200-day average, 3.4% below the 52-week high and +48.8% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+3.2%
- vs 50-day+2.5%
- vs 200-day+9.9%
- 52-week band3.4% off the high · +48.8% off the low
- Streak1 consecutive down session
- 50-day crossprice crossed up through the 50-day 8 sessions ago
- Stochastic%K 68.2 · %D 65.1 · bull cross
Continue: the JNJ chart & overview · the earnings record · the signal board
FAQ · from the current data · as of 2026-11-05
Quick answers
What is the current Closelooknet signal on JNJ?
Uptrend stack intact — Trades +2.5% vs the 50-day and +9.9% vs the 200-day average, 3.4% below the 52-week high and +48.8% off the 52-week low. Computed from daily closes. As of 2026-11-05; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is JNJ above its 50-day and 200-day moving averages?
As of 2026-11-05, Johnson & Johnson trades +2.5% above its 50-day and +9.9% above its 200-day average, with the 20-day +3.2% away.
How far is JNJ from its 52-week high?
3.4% below the 52-week high and 48.8% above the 52-week low, as of 2026-11-05.
Mentioned on Closelooknet
Where JNJ appears in the diary — 11 pieces, newest first. Every link is our own writing.
Go deeper
Long reads
- Covered Calls for Income — the Dividend Aristocrats Approach
The list overlaps heavily with the consumer-staples / industrials / healthcare slow-compounders: KO, PG, JNJ, KMB, MMM, ED, ABT, MMC, EMR, ITW, and on.
Dailies
- AI Trade — Asia bounces, Kospi +3.3%; Nasdaq-100 holds its support line, Jakarta −10.8% on MSCI
Going into the last day: UnitedHealth 406.89 (+7.7% vs entry, above its paid line of 389.09); Wells Fargo 82.82 (+2.6%, paid line 83.17); Johnson & Johnson 253.66 (+2.0%); JPMorgan 336.18 (+1.4%); Goldman Sachs 892.61 (+0.1%); Citi 123.39…
- ASML — record €11.7 billion quarter and sold out into 2028; inflation at 12:30 UTC
Outside the banks, Johnson & Johnson dropped 5.7% to $248.61 after its report.
- Earnings — J&J −6.2% and Citi −3.8% after beats; Micron −5.1%, chip fund back under its 50-day line
Johnson & Johnson is down 6.2% after topping estimates and raising its outlook; Citigroup is down 3.8% after a beat on both lines.
- Temperature 59 — Rubin surges 25% monthly as cointegration breaks pile up
The top five hits are all support-confluence reads — NOC, MCD, PFE, JNJ, and MA — with the two highest-confidence names, NOC and MCD, carrying red-regime labels.
- Temperature 59 — first crack in semis, defensives bid
The Pattern Scanner registered 28 active signals, top five clustered in support-confluence setups: NOC at 41 confidence and MCD at 37, both in red regimes, alongside PFE and JNJ in yellow.
- Temperature 61 — semis overheating into the catalyst window
The Pattern Scanner registered 26 active signals, with the top five concentrated in support-confluence setups across pharma, defense, and consumer staples — AZN and JNJ lead at 44 and 43 confidence respectively, both in yellow-regime.
- Temperature 62 — Euro-AI leads broad multi-week rally
AZN, JNJ and NOW are flagged in yellow or green regimes — defensives and high-quality software finding floors.
- Temperature 57 — Rubin surges 2.3%, seven cointegration breaks widen
The top hits — AZN, NOC, JNJ, MCD, LMT — are defensive and industrial names carrying yellow or red regime labels.
Related in the Closelooknet universe
then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ORNAV.HE Orion Oyj Aindustry
- ORNBV.HE Orion Oyj Bindustry
- SAN.PA Sanofi SAindustry
- AMGN Amgen Incindustry
- AZN.L AstraZeneca PLCindustry
- GSK GSK plcindustry
- LLY Eli Lilly and Companyindustry
- SNY Sanofi ADRindustry
- 002422.SHE Sichuan Kelun Pharmaceutical Co Ltdindustry
- GILD Gilead Sciences Incindustry
- ABBV AbbVie Incindustry
- BIIB Biogen Incindustry
- PFE Pfizer Incindustry
- BMY Bristol-Myers Squibb Companyindustry
- MRK Merck & Company Incindustry
- OGN Organon & Coindustry
- AZN AstraZeneca PLCindustry
- CMHC.SW COSMO N NVindustry
- HALO Halozyme Therapeutics Incsector
- ONC BeOne Medicines AGsector